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Highlights
• The global burden of human trichinellosis is low, with a mean estimated loss of 76 healthy 
life years per billion people per year.
• The WHO European region is responsible for 69% of the global burden.
• Chronic trichinellosis could significantly increase the global burden of trichinellosis, but there
is large uncertainty about its true extent and nature.
• These findings support the revision of current Trichinella meat inspection regulations and 
their replacement by more cost-effective prevention programs.
Abstract
Trichinellosis is a cosmopolitan foodborne disease that may result in severe health disorders and 
even death. Despite international awareness on the public health risk associated with 
trichinellosis, data on its public health impact are still lacking. Therefore, we assessed for the first
time the global burden of trichinellosis using the Disability-Adjusted Life Year (DALY) metric. 
The number of DALYs due to trichinellosis was estimated to be 76 per billion per year (95% CrI: 
38–129), much lower than for other foodborne parasitic diseases and in sharp contrast to the high 
budget allocated to prevent the disease in many industrialized countries. To decrease the 
uncertainty around the current estimates, more knowledge is needed on the nature and extent of 
chronic trichinellosis and on the level of underreporting of clinical trichinellosis in different parts 
of the world.
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1. Introduction
Trichinellosis is a foodborne helminthic disease caused by one of several Trichinella species 
(Pozio and Zarlenga, 2013). Infection occurs when humans consume raw or undercooked meat of
different animal origins, e.g. pork, horse or game, containing muscle larvae (Gottstein et al., 
2009). Clinical signs of trichinellosis are various and not pathognomonic, making the diagnosis 
complicated, which leads to medical misclassification and underreporting. In the acute phase of 
the disease, infected individuals may present with gastrointestinal disorders such as diarrhoea, but
also with myalgia, fever, headache and facial oedema (Pozio et al., 2003). Whether or not a 
chronic form of trichinellosis exists is still under debate. The few studies that included follow-up 
over a longer time span indicated that myalgia and fatigue can persist for four months and, in a 
substantial proportion of cases, for up to two years (Nemet et al., 2009).
Although the actual public health impact of human trichinellosis has not yet been quantified, 
many industrialized countries are implementing strict and costly programmes to prevent the 
disease at the farm and slaughterhouse level. Indeed, each year, more than 167 million pigs are 
tested in the EU for Trichinella spp. by the artificial digestion method under the Commission 
Regulation (EC) 2075/2005 (Alban et al., 2011). With a mean expense of €1,31 per tested pig 
tested, a gross estimate of the annual cost linked to pig testing in the EU amounts to €220 million 
(Kapel, 2005). Other sources report an annual cost of about US$ 570 million in the EU for 
inspection for Trichinella and US$ 1 billion due to swine and human trichinellosis in the United 
States, primarily for health regulatory activities to prevent infection (Murrell and Pozio, 2000).
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The aim of the current study is to provide the first global burden of disease assessment for 
trichinellosis, based on the Disability-Adjusted Life Year (DALY) metric. This assessment is part 
of a larger exercise of the World Health Organization (WHO) to assess to global burden of all 
major foodborne diseases (Torgerson et al., 2014).
2. Materials and methods
2.1. Incidence and mortality
The estimation of the global incidence and mortality of trichinellosis presented here is based on 
the results of a recent systematic review on the worldwide epidemiology and clinical impact of 
human trichinellosis between 1986 and 2009 (Murrell and Pozio, 2011). Searches of six 
international databases yielded 494 reports, of which 261 were selected for data extraction after 
applying strict relevance and reliability criteria. From 1986 through 2009, there were 65,818 
cases and 42 deaths reported from 41 countries. The apparent annual incidence and mortality of 
trichinellosis was calculated by dividing the average number of cases and deaths in this 24-year 
period by the 1997 mid-year population (WHO, 1998). As in Murrell and Pozio (2011), we 
stratified our incidence and mortality rates by WHO region.
Because of the important variability in the reporting of the disease, the apparent incidence and 
mortality rates were adjusted to account for underreporting of the cases due to under-
ascertainment, medical misclassification and/or absence of effective surveillance systems. 
Recently, Vu Thi et al. (2013) have shown that in a trichinellosis outbreak in Vietnam, 6 patients 
had sought health care while another 30 putative trichinellosis cases had not. As the detection of 
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putative trichinellosis cases was based on serology, the estimate of six "true" trichinellosis cases 
per "apparent" case is likely an overestimation. However, given the scarcity of data on the level 
of underreporting for trichinellosis, we applied this correction factor to the incidence and 
mortality rates in the AFRO, EMRO, SEARO and WPRO WHO regions, in order to obtain a 
plausible upper bound for the true incidence and mortality rates. For the EURO and AMRO 
WHO regions, where surveillance is likely more efficient, we arbitrarily applied, in the absence 
of any data,  a correction factor of two, implying that for every reported case there is assumed to 
be a non-reported one.
2.2. Disability-Adjusted Life Years
The DALY metric has been developed as an alternative method to estimate, compare and rank the
burden of diseases by including both fatal and non-fatal health outcomes. DALYs can be 
interpreted as the number of healthy life years lost due to a disease, and result from the sum of 
the number of years lived with a disability (YLDs) due to the disease, and the number of years of 
life lost due to disease-related mortality (YLLs) (Murray, 1994). This concept was first used in 
the Global Burden of Disease (GBD) study, a comprehensive assessment of the worldwide health 
impact of more than 100 diseases and risk factors. The calculations of the GBD have been 
updated several times by both the World Health Organization (WHO) and the Institute for Health 
Metrics and Evaluation (Murray and Lopez, 2013).
In an pathogen-based DALY calculation, DALYs are the sum of the YLDs for the non-fatal 
outcomes of the pathogen and the YLLs for the fatal outcomes (Mangen et al., 2013). The YLDs 
are calculated as the product of the number of cases, the duration of the outcome until remission 
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or death in years, and a disability weight (DW), expressing the severity of the outcome on a scale 
from zero to one. The YLLs are calculated as the product of the number of deaths and the 
standard life expectancy at age of death in years. Instead of absolute numbers, DALYs can also 
be calculated as rates, expressing e.g. the number of healthy life years lost per 100,000 people per
year.
The incidence and mortality rates were estimated as described in section (2.1). To account for the 
uncertainty in the level of underreporting, we let the regional incidence and mortality rates vary 
uniformly between their raw and adjusted values. To be able to calculate sex and age stratified 
DALYs, we further stratified these incidence and mortality rates based on Murrell and Pozio 
(2011), who found that 51% of cases were male and the majority of cases was between 20 and 50 
years of age, with a median of 33.1. A generalized Beta distribution was fitted to the latter 
estimates to define the full distribution of cases from age 0 to 90.
In absence of data on the probability of occurrence of the major clinical symptoms of acute 
trichinellosis, we assumed, as a worst case scenario, that all patients would develop diarrhoea, 
facial oedema, myalgia and fever/headache. Because no specific DW for trichinellosis is 
available, DWs were derived for each the outcomes separately. The four clinical symptoms were 
respectively matched to the GBD2010 health states Diarrhoea: moderate (DW=0.202), 
Disfigurement: level 2, with itch or pain (DW=0.187), Musculoskeletal problems: generalised, 
moderate (DW=0.292), and Infectious disease: acute episode, severe (DW=0.210) (Salomon et 
al., 2012). These four DWs were then aggregated using the multiplicative method, which defines 
6
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
6
the aggregated DW as 1 –∑
i
(1 −DW i )=0.637 . This approach avoids that aggregated DWs would become larger 
than one and thus "worse than death" (Haagsma et al., 2011).
Based on the systematic review, disease duration ranged from 21.5 to 70 days (Murrell and Pozio,
2011). These values were divided by 365 to express the duration in years.
Given the controversy regarding the existence and nature of chronic trichinellosis, we performed 
a scenario analysis to assess how the global burden of trichinellosis would change if chronic 
trichinellosis would indeed exist. Based on a case series of chronic trichinellosis patients from 
Romania (Nemet et al., 2009), we assumed that 10 to 40% of acute trichinellosis patients would 
developed chronic sequelae, which would last for a maximum of two years. We further assumed 
that such patients would suffer from myalgia and fatigue. Again, proxy DWs were derived from 
Salomon et al. (2012), i.e., Musculoskeletal problems: generalised, moderate (DW=0.292) and 
Infectious disease: post-acute consequences (DW=0.254), respectively. These were then 
combined using the multiplicative approach, yielding an aggregated DW of 0.472.
All DALY calculations were performed in a probabilistic framework, using 10,000 Monte Carlo 
simulations to compute DALY credible intervals (CrI) based on the uncertainty in the various 
input parameters. The calculations were performed in R 3.0.1 (R Core Team, 2013), based on the 
functions available in the DALY package version 1.2.0 (Devleesschauwer et al., 2013a). DALYs 
were calculated as rates per billion people and, for comparison purposes, as absolute values by 
applying the DALY rates to the 2010 population (available from 
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http://www.census.gov/ipc/www/idb/worldpop.php). No age weighting or time discounting was 
applied.
3. Results
Table 1 summarizes the global and regional Trichinella burden estimates. Between 1986 and 
2009, an average of 2739 cases and 2 deaths were reported per year (Murrell and Pozio, 2011). 
When applying our correction factors, upper limits were obtained of 5751 cases and 5 deaths per 
year. These estimates led to a global incidence rate of 469.2 to 985.3 cases per billion per year, 
and a global mortality rate of 0.300 to 0.828 per billion per year. The estimated global number of 
DALYs per billion per year was 76 (95% CrI: 38–129; Figure 1). When applied to the 2010 
population, this led to a number of 523 DALYs (95% CrI: 263–882). The WHO European region 
was responsible for 69% (95% CrI: 61%–77%) of this global burden. The scenario analysis 
further showed that including chronic trichinellosis could increase the global burden by 53% 
(95% CrI: 26%–84%), to an estimated number of 1108 DALYs (95% CrI: 405–2386).
[TABLE 1]
[FIGURE 1]
4. Discussion
This study provides the first estimate of the global burden of trichinellosis expressed in DALYs. 
Given the limited data and knowledge on some key clinical aspects of human trichinellosis, the 
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presented estimates have some limitations. First, due to a lack of knowledge on the occurrence of 
the different possible clinical outcomes of trichinellosis, we assumed that all cases present with 
diarrhoea, facial oedema, myalgia and fever/headache. This represents a worst case scenario, and 
may thus overestimate the global burden of trichinellosis. Second, as no DWs are available for 
facial oedema or myalgia, we had to apply DWs for "proxy" health outcomes. Third, because the 
existence of a chronic form of trichinellosis is still questioned, we did not include it in our base 
estimates. Our scenario analysis showed however that chronic trichinellosis, if it were to exist, 
could greatly increase the global burden of trichinellosis. This highlights the need for more long-
term follow-up studies, studying the extent and nature of chronic trichinellosis, and its correlation
with the severity during the acute stage and the time between infection and treatment. Finally, 
given the lack of information on the level of underreporting of clinical trichinellosis in most parts
of the world, we had to resort to arbitrary correction factors to derive plausible upper bounds of 
the "true" incidence and mortality rates. Further studies are needed to generate evidence-based 
correction factors.
Notwithstanding these limitations, even when considering the upper bounds of the DALY 
credible intervals, the global burden of trichinellosis appears very low compared to other 
foodborne parasitic diseases. Indeed,  foodborne trematodoses, alveolar echinococcosis and 
congenital toxoplasmosis are each responsible for several hundreds of thousands of DALYs 
worldwide (Furst et al., 2012; Torgerson et al., 2010; Torgerson and Mastroiacovo, 2013). 
Moreover, the global burden of trichinellosis appears lower than the burden of neurocysticercosis 
and congenital toxoplasmosis in Nepal alone (Devleesschauwer et al., 2014).
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The low burden of trichinellosis also contrasts with the high yearly budget allocated to prevent 
the disease at farm and slaughterhouse level in many industrialized countries (Kapel, 2005; 
Murrell and Pozio, 2000). The question arises whether the low burden of trichinellosis results 
from these strong prevention measures or whether the latter are obsolete in industrialized 
countries where pigs are intensively reared. Both statements are probably true. Trichinella meat 
inspection probably prevented many cases of human infections decades ago when small pig farms
with outdoor access were more common. The controlled housing of pig farming systems literally 
eliminated any possible route of infection, avoiding any contact between pigs and the infected 
environment, i.e., infected meat from wild or other domestic animals (Thompson, 2013). Within 
the EU, however, both controlled and non-controlled pig farming systems are still present, the 
latter especially in central and eastern Europe. Moreover, organic pig farming allowing free-
ranging of the animals is an emerging trend in western European countries and in the US (15). 
Therefore, the EU and the US Department of Agriculture (USDA) are currently considering new 
regulations that would exempt Trichinella-free certified pig farms from meat inspection 
(SANCO/2378/2006 amending EC No 2075/2005; (Pyburn et al., 2005)). Certified farms would 
be subjected to a strict regulation and should fulfil specific criteria including physical barriers 
which prevent contact with other animals, animal carcasses, or exposure to meat-containing 
waste (Kapel, 2005; Murrell, 2013). In addition to these new measures, the EU permits 
exemption from meat inspection to regions or countries that obtained negligible risk status based 
on risk-based surveillance as it is the case for Denmark and Belgium (EC, No 2075/2005). These 
evolutions towards risk-based control strategies for Trichinella are further supported by the 
observation that an increasing number of the human trichinellosis cases, and thus of trichinellosis 
DALYs, can be attributed to other animals than domestic pigs (Murrell and Pozio, 2011).
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5. Conclusion
Globally, trichinellosis is responsible for a minimal human health burden, strengthening the need 
for replacing current Trichinella meat inspection regulations by more cost-effective protocols. To 
provide a full picture of the disease burden and to decrease the uncertainty around the available 
estimates, there is a need for studies on the level of underreporting of clinical trichinellosis and 
for prospective epidemiological and clinical studies, considering both acute and chronic 
syndromes.
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Tables
Table 1: Trichinellosis incidence rates, mortality rates, DALY rates and 2010 DALYs
WHO regiona Incidence rate per 1e9 
(raw; adjustedb)
Mortality rate per 1e9 
(raw; adjustedb)
DALY rate per 1e9 
(95% CrI)c
2010 DALYs (95% 
CrI)c
AFRO 1.9; 11.4 0.068; 0.408 12 (4–20) 10 (3–17)
AMRO 377.7; 755.4 0.526; 1.052 82 (48–128) 76 (44–119)
EMRO 4.4; 26.4 0.000; 0.000 1 (0–3) 1 (0–2)
EURO 2728.8; 5457.6 1.151; 2.301 405 (202–681) 363 (181–610)
SEARO 6.3; 37.6 0.029; 0.172 6 (2–11) 12 (4–21)
WPRO 34.3; 205.6 0.153; 0.918 34 (12–61) 62 (21–110)
Global 469.2; 985.3 0.300; 0.828 76 (38–129) 523 (263–882)
a AFRO: WHO African Region; AMRO: WHO Region of the Americas; EMRO: WHO Eastern Mediterranean Region; EURO: WHO 
European Region; SEARO: WHO South-East Asia Region; WPRO: WHO Western Pacific Region.
b To adjust for underreporting, an correction factor of 6 was assumed for AFRO, EMRO, SEARO and WPRO, and an correction factor 
of 2 for AMRO and EURO.
c CrI = Credible Interval.
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Figure captions
Figure 1. Global burden of trichinellosis by WHO region
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